Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |